SEC Form 4 · accession 0001209191-18-060900
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles W McHugh
Officer — Sr VP & Princ. Acctg Officer
Period of report
Dec 1, 2018
Accepted (ET)
Dec 4, 2018 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 1, 2018 | M | 8,450 | — | A | 66,684 | D | |
| Ordinary Shares | Dec 1, 2018 | F | 3,744 | $19.98 | D | 62,940 | D | |
| Ordinary Shares | holding | — | — | — | 1,000 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 1, 2018 | M | 8,450 | D | — | — | Ordinary Shares | 8,450 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On December 1, 2014, the reporting person was granted 33,800 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.